生物加工技术市场报告：2030 年趋势、预测与竞争分析

生物製程技术趋势与预测

到 2030 年，全球生物製程技术市场预计将达到 717 亿美元，2024 年至 2030 年复合年增长率为 12.3%。该市场的主要驱动因素是对下一代生物基产品的需求不断增长以及慢性病盛行率的上升。全球生物製程技术市场的未来充满希望，生物製药、契约製造和学术研究市场都有机会。

Lucintel 预测，生技药品安全测试将在预测期内达到最高成长。

在这个市场中，生物製药预计将在预测期内实现最高成长。

预计北美地区在预测期内将出现最高的成长。

生物製程技术市场新趋势

生物製程技术市场正在出现各种趋势，这些趋势将成为其未来的特征，反映了技术进步、工业实践的创新以及对永续性和效率的需求。相关人员需要了解所有这些，才能了解这个不断发展的生物技术过程的前景。

• 采用连续加工：连续加工在生物加工技术中正在蓬勃发展。此过程意味着原材料和产品连续流过该过程，以确保提高效率、节省成本和可扩展性。连续製程可以更好地控制和优化生物製程，从而提高产量并降低生产成本。
• 整合即时分析：它还能够实现生物製程技术的转型。可以即时监控和控制的先进感测器和资料分析工具被整合到生物製程系统中。这种趋势可以实现更精细的控制、更快的周转和更顺畅的製程，从而提高产品品质并减少停机时间。
• 强调永续性：人们越来越重视开发永续的生物加工技术。这不仅加快了流程，还减少了与传统方法相关的废弃物、能源消耗和环境影响。除了应用新的绿色生物工艺和绿色材料之外，永续性正在成为响应生物工艺行业技术创新和法规的驱动力。
• 细胞株开发的新进展：细胞株开发的创新正在改善生物製药和其他生物产品的生产。正在开发新技术以提高细胞株内的稳定性、生产力和一致性。这对于生物加工行业的生产扩张和高品质生产至关重要。
• 个人化医疗的发展：个人化医疗的成长趋势正在推动生物加工技术的创新。此类治疗和处理需要单独定制的治疗并且需要专门的生物加工技术和方法。因此，更灵活、更具适应性的生物加工系统将继续推动产业满足个人化医疗的需求。

生物製程技术市场的未来趋势包括连续处理、即时分析和永续性。创新和变革的其他驱动力是细胞株开发的进步和个人化医疗的发展。这些，加上效率、扩充性和环境责任的提高，为生物加工技术带来了不同的未来。

生物製程技术市场的最新趋势

生物加工技术市场的最新趋势显示一些重大进步正在改变该行业领域。新兴市场的开拓意味着透过创新技术和不断变化的需求提高效率、扩充性和永续性。

• 连续生物加工的引入：连续生物加工技术因提供效率和成本节约而越来越被接受。该技术允许连续执行生物製程，从而提供比传统批量处理更好的製程控制、更高的产量和更快的生产时间。
• 一次性技术的发展：在快速成长的领域中，一次性技术在生物加工中的应用开始占据主导地位。应用一次性反应器和过滤系统的主要优点包括灵活性、污染风险低和整体成本节省。事实证明，此类技术在小规模生产和快速开发週期中非常有用。
• 先进的 PAT 系统：现已整合到生物製程系统中，以增强製程监控和控制。先进的感测器和分析工具提供关键过程参数的即时资料，以促进製程最佳化、品管和快速解决问题。
• 绿色生物工艺开发：显然强调开发减少环境影响的绿色生物工艺。已经报导了各种创新，包括节能反应器、废弃物减少策略和可再生原材料。这些发展将全球永续性目标和监管要求付诸实践。
• 生物製药产能扩张：生物製药产能扩张趋势高涨。这包括扩大生产设施，透过先进技术和自动化实现生物製药生产规模扩大、製程优化和更高效率。

生物加工技术市场的最新趋势包括连续生物加工、一次性技术和绿色生物加工。此后，这种动态导致了该行业的重大变化。透过提高效率、扩充性、环境永续性以及为生物加工技术设定新标准，进步正在重塑 CMO 格局。

生物加工技术市场的策略性成长机会

生物加工技术的成长机会正在广泛的应用中展开，这主要是由于技术进步、对生物製药的需求不断增加以及对永续解决方案的推动。对于寻求利用市场趋势实现成长的相关人员来说，识别这些机会非常重要。

• 生物製药製造：对生物製药的兴趣和需求为生物加工技术创造了成长机会。连续加工和一次性技术可以改进生产技术并提高可扩展性，以满足治疗性蛋白质和疫苗的需求。
• 农业生物技术：生物基农药、生物基肥料等的发展潜力大。生物加工技术的创新将进一步提高这些永续产品的生产水准。它们是化学产品的永续替代品，有助于维持环保的农业实践。
• 环境生物修復：人们对生物处理技术在环境生物修復的应用越来越感兴趣。使用微生物净化污染物和废弃物的更先进、更有效率的技术正在出现。因此，它为企业解决环境问题提供了新的机会，并为永续问题提供更广泛的解决方案。
• 生物基化学品和材料：生物基化学品和材料的发展为各个行业带来了成长机会。生物加工技术的进步正在为石化产品（例如生物分解性塑胶和生物基溶剂）的永续製造替代品铺平道路。
• 个人化医疗的发展：生物加工技术开闢了开发特定治疗方法和疗法的新途径。细胞株开发阶段和生物加工技术的持续创新将继续支持个人化医疗产品的生产并推动该领域的成长。

这些策略性成长机会包括生物製药製造、农业生物技术、环境生物修復、生物衍生化学品和个人化医疗。这些策略性成长机会反映了生物製程技术产业的未来，该产业对永续和创新解决方案的需求量很大。

生物工艺技术市场的驱动因素与挑战

影响生物加工技术市场的关键驱动因素和挑战包括技术、经济和监管因素。这些对于确定行业内的成长速度、创新率和营运效率水准非常重要。一方面，技术进步推动了更有效率、更容易扩展的流程的创建和开发，而经济因素和监管负担则影响市场和采用率。

推动生物製程技术市场的因素包括：

1.技术改进：生物加工技术的创新，如连续加工、改进的感测器和自动化，将显着推动市场成长。这些改进使流程更加高效、扩充性和可控，从而提高产量比率并降低生产成本。技术的进步也将使新的、更有效的生物产品的配方成为可能，以满足製药业和其他与环境管理相关的行业日益增长的需求。

2.生物製药需求的成长：生物製药需求的成长要素，包括人口老化和慢性病发病率上升等人口因素，也正在加强该产业作为生物加工技术市场的驱动力。此外，生物製药需求需要透过生物加工技术的发展来进一步补充，以提高治疗性蛋白质、疫苗和其他生技药品的生产效率和扩充性。对高品质、高性价比生物製药的追求推动了生物加工技术的创造性创新和投资。

3. 强调环境永续性的法律规范将为应用于生物过程的技术提供动力。有关减少废弃物、提高能源效率和使用可再生资源的法规促进了绿色生物製程的发展。遵守此类法规不仅符合组织制定的环境标准，还可以透过回应全球永续性要求来提供市场竞争优势。

生物製程技术市场面临的挑战包括：

1. 另一个主要限制因素是营运成本高。设备、原料和营运的高成本是生物加工技术的主要挑战。这可能会阻止小型企业进入这些行业并推广新技术。高生产成本与生物产品的定价有关，这影响了市场竞争力和可近性。

2. 监管合规性：对于生物製程技术市场来说，管理许多复杂且严格的监管要求是复杂且耗时的。有关生物製药、环境标准和安全协议的各种法规需要大量的资源和能力。由于需要时间和成本来确保满足这些法规，产品开发和市场开拓可能会被推迟。

3.技术复杂性：生物加工技术的广泛应用需要技术复杂性。一些依赖专业知识和技术技能的先进技术需要概念化和实施，但这并不一定适用于所有组织。因此，技术复杂性成为创新解决方案实施的瓶颈，并影响生物製程业务的效率。

在技​​术进步、对永续性的监管支持、个人化医疗的兴起以及对创新者的经济奖励的推动下，竞争激烈的生物加工技术市场对生物製药的需求不断增加。另一方面，必须克服高生产成本、监管合规性和技术复杂性，才能充分发挥市场潜力。

生物製程技术（按细分市场）

本研究按产品类型、应用、最终用途和地区对全球生物加工技术进行了预测。

国家生物加工技术市场前景

由于生物技术市场的快速开拓、生物製药需求的增加以及法规环境的变化，这个生物製程技术市场仍在经历深刻的变化。该领域的发展正在使製药、农业和环境管理等行业的生物过程更加高效、扩充性和永续性。美国、中国、德国、印度和日本等主要市场处于这项转型的中心，每个市场都以自己的方式取得了有趣的进展和策略。

• 美国：总体而言，美国生物技术公司越来越多地利用先进的生物製程平台与即时分析相结合，以进一步提高製造效率和经济效益。这包括创新的连续加工技术和先进的细胞培养系统，使生物製药製造流程更加高效，并提高整体製程的可扩展性和产量。
• 中国 为了实现具有成本效益的运营，中国正在迅速增强其大规模生物加工技术的能力。最新消息涉及生物製造基础设施投资和先进过程分析技术 - PAT 的引进。中国公司也与国际公司合作，引进最尖端科技，以提高其生物加工能力。
• 德国在将永续实践融入生物加工技术方面处于领先地位。主要的演变是绿色生物製程的发展，最大限度地减少废弃物产生和能源消耗。德国也投资优化反应器的设计和使用先进的发酵技术，提高生物技术下进行的製程的效率和环境友善性。
• 印度 印度的生物加工技术市场仍在发展中，但目标是低成本、可扩展的生物製药生产。最近的技术进展包括一次性反应器系统的引入和微生物发酵技术的改进。印度公司也致力于加强与生物相似药和其他高价值生物产品相关的能力，并利用这一机会来满足国内和国际市场的需求。
• 日本 日本正在透过製程整合和自动化方面的广泛创新实现其生物加工技术的现代化。最近的趋势包括采用高通量筛检技术和引入智慧生物製程系统。此外，日本主要公司正致力于利用精密生物技术开发生物基化学品和材料，这正在推动该领域的成长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球生物製程技术市场预计将达到 717 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球生物製程技术市场预计将以12.3%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 该市场的主要驱动力是对下一代生物基产品的需求不断增长以及慢性病患病率的上升。

Q4.市场的主要细分市场是：

A4. 生物加工技术市场的未来充满希望，生物製药、契约製造和学术研究市场充满机会。

Q5.市场的主要企业是：

A5. 生物製程技术的主要企业如下：

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，生技药品安全测试将在预测期内达到最高成长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 预计北美地区在预测期内成长最快。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球生物製程技术市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球生物製程技术市场趋势（2018-2023）与预测（2024-2030）
• 按产品类型分類的生物加工技术的全球市场
  • 生物製药安全检测
  • 细胞培养
  • 细胞增殖
  • 细胞株开发
  • 流式细胞技术
  • 切向流过滤
  • 流式细胞技术
• 按应用分類的全球生物加工技术市场
  • 抗生素
  • 生物相似药
  • 重组蛋白
  • 其他的
• 全球生物加工技术市场（按最终用途）
  • 生物製药公司
  • 契约製造组织
  • 学术研究所
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 按地区分類的生物工艺技术市场
• 北美生物製程技术市场
• 欧洲生物加工技术市场
• 亚太生物製程技术市场
• 其他区域生物加工技术市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按产品类型分類的全球生物工艺技术市场成长机会
  • 全球生物工艺技术市场成长机会（按应用）
  • 全球生物工艺技术市场成长机会（依最终用途）
  • 按地区分類的全球生物工艺技术市场成长机会
• 全球生物工艺技术市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球生物工艺技术市场的产能
  • 全球生物工艺技术市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Bio-Process Technology Trends and Forecast

The future of the global bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets. The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030 with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.

Lucintel forecasts that biologics safety testing is expected to witness the highest growth over the forecast period.

Within this market, biopharmaceutical is expected to witness the highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Emerging Trends in the Bio-Process Technology Market

Various trends emerge in the bio-processing technology market to characterize its future, reflecting improvements in technologies, innovations in practices of industries, demands for sustainability, and efficiency. All these call for understanding on the part of the stakeholders if they ever hope to know their way around in this evolving landscape of bio-technology processes.

• Adopting Continuous Processing: In bioprocess technology, continuous processing is gaining momentum. The process means the raw material and product flow continuously through the process to ensure gains in efficiency, cost reduction, and scalability improvement. Continuous processing allows for superior control and optimization of bioprocesses-leading to higher yields and lower production costs.
• Integrating real-time analytics: will also allow the transformation of bio-process technology. Advanced sensors and data analytics tools capable of monitoring and controlling in real time are integrated with bioprocessing systems. The trend enables finer control, faster turnarounds, and a smoother process flow that results in higher product quality and less downtime.
• Sustainability Focus: There is an increasing emphasis on the development of sustainable bio-process technologies. This not only Quickens the processes but reduces wastes, energy consumption, and environmental impacts associated with conventional methods. Besides applying new green bioprocesses and eco-friendly materials, sustainability is increasingly a driver for innovation and keeping up with regulations in the bio-process industry.
• New Advances in Cell Line Development: Innovations within cell line development are improving the production of biopharmaceuticals and other bio-products. New techniques have been developed that enhance stability, productivity, and consistency within the cell line. This is quite important for scaling up production and high-quality output in the bio-process industry.
• Growth in Personalized Medicine: The increasing trend of personalized medicine drives innovation in bio-process technology. For such therapies and treatments, individually tailored therapies call for specialized bioprocessing techniques and technologies. This will continue to drive the industry towards more flexible and adaptable bio-process systems to meet the needs of personalized medicine.

Upcoming trends in the bio-process technology market include continuous processing, real-time analytics, and sustainability. The other driving forces for innovation and change are the advances in cell line development and growth in personalized medicine. These are coupled with efficiency, scalability, and environmental responsibility improvements; hence, promising a different future for bio-process technology.

Recent Developments in the Bio-Process Technology Market

Recent developments in the bio-process technology market demonstrate several key advances transforming industry segments. The developments epitomize increasing efficiency, scalability, and sustainability through innovative technologies and the evolution of market demand.

• Continuous Bioprocessing Implementation: Continuous bioprocessing technologies are increasingly gaining acceptance for bringing efficiencies and reducing costs. The technique allows for the continuous running of bioprocesses, thus offering greater process control with higher yields and faster production times than the conventional batch processing.
• Single-Use Technologies Development: Among the fastest-growing areas, the application of single-use technologies in bioprocessing is starting to prevail. The main advantages of applying single-use bioreactors and filtration systems include flexibility, low contamination risks, and overall cost decrease. Such techniques have been found useful in small-scale productions and rapid development cycles.
• Advanced PAT systems: are now integrated into bioprocessing systems to enhance process monitoring and control. Advanced sensors and analytical tools are providing real-time data on critical process parameters, thus driving better process optimization, quality control, and quicker problem resolution.
• Green Bioprocess Development: There is clear emphasis on the development of green bioprocesses that have limited environmental impact. Various innovations reported involve energy-efficient bioreactors, strategies relating to waste reduction, and renewable feedstocks. Such developments put into practice global sustainability goals and regulatory imperatives.
• Expanding Biopharmaceutical Manufacturing Capacity: There is an increasing trend towards the expansion of capacity in the manufacturing of biopharmaceuticals due to high demands. This encompasses the expansion in production facilities to achieve scale-up, process optimization, and enhancement of efficiency in manufacturing biopharmaceuticals through sophisticated technologies and automation.

Recent development within the bio-process technology market includes continuous bioprocessing, single-use technologies, and green bioprocess. The dynamics, because of this, have ever since been driving significant alteration in the industry. Advancements are improving efficiency, scalability, and environmental sustainability that reshape the CMO landscape by setting new standards for bio-process technology.

Strategic Growth Opportunities for Bio-Process Technology Market

This can be observed in the wide range of applications that the development of opportunities in bio-process technology growth has, mainly because of technological advances, increasing demand for biopharmaceuticals, and the drive toward sustainable solutions. Identification of these opportunities will be important for stakeholders, which are willing to capitalize on market trends for growth.

• Biopharmaceutical Manufacturing: Interest in and demand for biopharmaceuticals create growth opportunities in bioprocessing technology. Continuous processing and single-use technologies make production techniques better and allow companies to increase scalability with demands for therapeutic proteins and vaccines.
• Agricultural Biotechnology: Large potential is existing in the development of bio-based pesticides, bio-based fertilizers, and many others. Innovation in bio-process technology further enhances production levels for these sustainable products. These are sustainable solutions to chemical-based products that help in maintaining environmentally friendly agricultural practices.
• Environmental Bioremediation: Interest in the application of bio-process technology to environmental bioremediation is on the increase. More sophisticated and efficient technologies involved in the use of microorganisms for cleaning up pollutants and waste are arising. It therefore presents another opportunity avenue for companies to solve environmental problems and contribute toward a broader solution of sustainability issues.
• Bio-based Chemicals and Materials: The development of bio-based chemicals and materials is opening up a series of opportunities for growth in different industries. Bio-process technological advances are paving the way for sustainable manufacturing of alternatives to petrochemical-based products like biodegradable plastics and bio-based solvents.
• The growth in personalized medicine: opens up new avenues in which bio-process technology will develop specific therapies and treatments. Ongoing innovations at the cell line development stage and in bioprocessing techniques go on to continue support for the production of personalized medical products, hence driving growth in the sector.

Some of these strategic growth opportunities are in biopharmaceutical manufacturing, agricultural biotechnology, environmental bioremediation, chemicals derived from biology, and personalized medicine. Such strategic growth opportunities reflect the future of the bioprocess technology industry as one with sustainable and innovative solutions in high demand.

Bio-Process Technology Market Driver and Challenges

The major drivers and challenges affecting the bio-process technology market include technological, economic, and regulatory considerations. These have become significant in determining the pace of growth, rate of innovation, and level of operating efficiency within the industry. While on one hand, technological advancement propels the creation and development of processes that could be much more efficient and easily scaled up, the economic element and regulatory burdens affect markets and rates of adoption.

The factors responsible for driving the bio-process technology market include:

1. Technological Improvement: Innovation in bio-process technology, including continuous processing, improved sensors, and automation-a process that greatly helps spur market growth. These improvements enhance process efficiency, scalability, and control, improving yields and reducing production costs. Improved technologies further enable the formulation of new, more efficient bioproducts to meet demand from the rising pharmaceutical industry, among others related to environmental management.

2. Increase in Biopharmaceutical Demand: Growth factors of biopharmaceutical demand, including demographic factors such as an aging population and rising prevalence of chronic diseases, also enhance this segment as a driver in the bio-process technology market. Moreover, biopharmaceutical demand needs to be further complemented with the development of bioprocessing technologies in order to enhance the efficiency and scalability of manufacturing therapeutic proteins, vaccines, and other biologics. The quest for high-quality, cost-effective biopharmaceuticals furthers creative innovation and investment in bioprocess technologies.

3. The regulatory support for sustainability: supportive regulatory frameworks emphasizing environmental sustainability give momentum to the technologies applied in bio-processes. Regulations relating to waste reduction, energy efficiency, and renewable resource usage are the motivating factors in formulating green bioprocesses. Compliance with such regulations does not only meet the environmental standards set by organizations but also offers competitive advantages in the market due to the response against the call of global sustainability.

Challenges in the bio-process technology market are:

1. Another major constraint is the high operational cost. The big cost of equipment, raw materials, and operation presents a great challenge for bio-process technologies. This could prevent small companies from entering into such industries or scaling up new technologies. High production costs must relate to the pricing of bioproducts affecting the market competitiveness and accessibility.

2. Regulatory Compliance: It is complex and time-consuming for the bio-process technology market to manage a number of complex and tight regulatory requirements. The various regulations on biopharmaceuticals, environmental standards, and safety protocols require a great deal of resources and competencies. Ensuring that these regulations have been met is time-consuming and expensive, thus this could delay the development and marketing of a product.

3. Technical Complexity: The use of bio-process technologies requires great technical complexity for their widespread adoption. There is a need to conceptualize and then implement several advanced technologies that depend upon one's expertise and technical skill, which may not necessarily be available to every organization. The technological complexities, therefore, act as a bottleneck towards the implementation of innovative solutions, thus impacting efficiency in operations involving bio-processes.

The highly competitive market of bio-process technology is driven by increasing demand for biopharmaceuticals, driven by technological advancement; regulatory support for sustainability; the rise of personalized medicine; and economic incentives to innovators. On the other hand, high production costs, along with regulatory compliance and technological complexities, need to be overcome in order to realize the full potential of the market.

List of Bio-Process Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-process technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-process technology companies profiled in this report include-

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Bio-Process Technology by Segment

The study includes a forecast for the global bio-process technology by product type, application, end use, and region.

Bio-Process Technology Market by Product Type [Analysis by Value from 2018 to 2030]:

• Biologics Safety Testing
• Cell Culture
• Cell Expansion
• Cell Line Development
• Flow Cytometry
• Tangential Flow Filtration
• Flow Cytometry

Bio-Process Technology Market by Application [Analysis by Value from 2018 to 2030]:

• Antibiotics
• Biosimilars
• Recombinant Proteins
• Others

Bio-Process Technology Market by End Use [Analysis by Value from 2018 to 2030]:

• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Academic Research Institute
• Others

Bio-Process Technology Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bio-Process Technology Market

This bio-process technology market is still subjected to serious transformation triggered by rapidly developing biotechnology, increasing demand for biopharmaceuticals, and changing regulatory environments. The developments in this field are enhancing the efficiency, scalability, and sustainability of bio-processes from industries such as pharmaceuticals, agriculture, and environmental management. Some major markets like the United States, China, Germany, India, and Japan form the hub of this transformation-they each carry some interesting advancement and strategies in their own significant way.

• United States: Automation and digitalization continue to advance in the bio-process technology market in the U.S. In general, biotechnology firms in the U.S. are increasingly using sophisticated bioprocessing platforms coupled with real-time analytics to achieve even higher efficiencies and economies in manufacturing. This includes innovative continuous processing technologies and advanced cell culture systems making the manufacturing process of biopharmaceuticals more efficient while improving the overall scalability and yield of the process.
• China: It is rapidly ramping up the capabilities of large-scale bio-process technology in China with the aim of making operations cost-effective. The latest news is about investments in biomanufacturing infrastructures and the implementation of advanced process analytical technologies-PAT. Chinese firms also partner with international companies to adopt state-of-the-art technologies in improving their bioprocessing capabilities.
• Germany: Integration of sustainable practices into bio-process technology is leading in Germany. The main evolutions have been the development of green bioprocesses to minimize the generation of waste and energy consumption. Optimizing the designs of bioreactors and using advanced fermentation technologies are also under investment in Germany, enhancing the efficiency and environmental friendliness of the processes under biotechnology.
• India: The Indian bioprocess technology market is still in development but aims to reach low-cost, scalable biopharmaceutical production. The latest technological advancements include single-use bioreactor system implementation and microbial fermentation technology improvement. Indian companies also work towards enhancing their capabilities related to biosimilars manufacturing and other high-value bioproducts, using this opportunity to fulfill the demand of domestic and international markets.
• Japan: Japan is modernizing the technology for bio-process through extensive innovation in integration of processes and automation. Few of the recent development works include the adoption of high-throughput screening technologies and the implementation of smart bioprocessing systems. Major companies in Japan are also targeting the development of bio-based chemicals and materials by using their precision biotechnology to act as the driving force behind their growth in this sector.

Features of the Global Bio-Process Technology Market

Market Size Estimates: Bio-process technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bio-process technology market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Bio-process technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the bio-process technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-process technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the bio-process technology market size?

Answer: The global bio-process technology market is expected to reach an estimated $71.7 billion by 2030.

Q2. What is the growth forecast for bio-process technology market?

Answer: The global bio-process technology market is expected to grow with a CAGR of 12.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the bio-process technology market?

Answer: The major drivers for this market are growing demand for next-generation bio-based products and rising prevalence of chronic diseases.

Q4. What are the major segments for bio-process technology market?

Answer: The future of the bio-process technology market looks promising with opportunities in the biopharmaceutical, contract manufacturing organization, and academic research institute markets.

Q5. Who are the key bio-process technology market companies?

Answer: Some of the key bio-process technology companies are as follows:

• Hoffmann-La Roche
• Sartorius
• Thermo Fisher Scientific
• Agilent
• ELITech

Q6. Which bio-process technology market segment will be the largest in future?

Answer: Lucintel forecasts that biologics safety testing is expected to witness the highest growth over the forecast period.

Q7. In bio-process technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-process technology market by product type (biologics safety testing, cell culture, cell expansion, cell line development, flow cytometry, tangential flow filtration, and flow cytometry), application (antibiotics, biosimilars, recombinant proteins, and others), end use (biopharmaceutical companies, contract manufacturing organizations, academic research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Bio-Process Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Bio-Process Technology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Bio-Process Technology Market by Product Type
  • 3.3.1: Biologics Safety Testing
  • 3.3.2: Cell Culture
  • 3.3.3: Cell Expansion
  • 3.3.4: Cell Line Development
  • 3.3.5: Flow Cytometry
  • 3.3.6: Tangential Flow Filtration
  • 3.3.7: Flow Cytometry
• 3.4: Global Bio-Process Technology Market by Application
  • 3.4.1: Antibiotics
  • 3.4.2: Biosimilars
  • 3.4.3: Recombinant Proteins
  • 3.4.4: Others
• 3.5: Global Bio-Process Technology Market by End Use
  • 3.5.1: Biopharmaceutical Companies
  • 3.5.2: Contract Manufacturing Organizations
  • 3.5.3: Academic Research Institute
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Bio-Process Technology Market by Region
• 4.2: North American Bio-Process Technology Market
  • 4.2.1: North American Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.2.2: North American Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.3: European Bio-Process Technology Market
  • 4.3.1: European Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.3.2: European Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.4: APAC Bio-Process Technology Market
  • 4.4.1: APAC Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.4.2: APAC Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others
• 4.5: ROW Bio-Process Technology Market
  • 4.5.1: ROW Bio-Process Technology Market by Product Type: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration, and Flow Cytometry
  • 4.5.2: ROW Bio-Process Technology Market by End Use: Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institute, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bio-Process Technology Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Bio-Process Technology Market by Application
  • 6.1.3: Growth Opportunities for the Global Bio-Process Technology Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bio-Process Technology Market by Region
• 6.2: Emerging Trends in the Global Bio-Process Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bio-Process Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Process Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Sartorius
• 7.3: Thermo Fisher Scientific
• 7.4: Agilent
• 7.5: ELITech